ResearchNurses.co Signs Contract to Support MS Studies in UK
ResearchNurses.co, a UK-based research nurses provider, has been awarded a contract with Nottingham University Hospitals Research and Innovation Department to provide research nursing services for clinical trials related to multiple sclerosis (MS).
As part of the project, research nurses will work alongside three major pharmaceutical sponsors as well as the MS Society in clinical trials for patients with relapsing-remitting MS and secondary progressive MS.
ResearchNurses.co will be working with some of the country’s leading neurologist consultants and investigators at the hospital including Professor Chris Constantinescu, Dr Bruno Gran and Dr Nikos Evangelou.
Dr Maria Koufali, Deputy Director for Research & Innovation at Nottingham University Hospitals said: “These studies are of huge importance to everyone affected by multiple sclerosis and we are keen to offer them to as many patients as possible. This will ensure patient access to innovative medicines but also improvement of our MS clinical services.
“ResearchNurses.co have been extremely quick and efficient at responding to our needs and have demonstrated that they are able to provide a wide-ranging and reliable service, helping us to ensure the integrity of our trial data as well as ensuring trial participants are comfortable throughout the study.”
Based at Nottingham’s Queens Medical Center, ResearchNurses.co will liaise with key sponsors and investigators to oversee and provide drug infusions and venepuncture, as well as providing processing and monitoring services.
John Illingworth, managing director of ResearchNurses.co added: “Many of our clients require nursing assistance and on-site support, our research nurses have extensive experience in fitting into existing team structures as well as expert knowledge of key protocols allowing them to provide a tailor made service and additional resource where it matters most.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
